Story thread · 2 reports / 2 sources
Boehringer Ingelheim expands equine health pipeline with acquisition of Evax AG
thestar.com · 12h · first report
Boehringer Ingelheim announced today that it has acquired Evax AG, a Swiss biotech company focused on equine health.
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.